These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25096022)

  • 1. Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study.
    Sicras-Mainar A; Maurino J; Ruiz-Beato E; Navarro-Artieda R
    BMC Psychiatry; 2014 Aug; 14():225. PubMed ID: 25096022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
    Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
    J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare cost, service use and mortality in major psychiatric disorders in Taiwan.
    Pan YJ; Kuo KH; Yeh LL
    J Affect Disord; 2019 Mar; 246():112-120. PubMed ID: 30580196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding pregabalin or gabapentin for the management of community-treated patients with painful diabetic peripheral neuropathy: a comparative cost analysis.
    Sicras A; Rejas J; Navarro R; Planas A
    Clin Drug Investig; 2013 Nov; 33(11):825-35. PubMed ID: 24085589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on healthcare resource utilization of multiple sclerosis in Spain.
    Sicras-Mainar A; Ruíz-Beato E; Navarro-Artieda R; Maurino J
    BMC Health Serv Res; 2017 Dec; 17(1):854. PubMed ID: 29284493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care.
    Hendrie HC; Tu W; Tabbey R; Purnell CE; Ambuehl RJ; Callahan CM
    Am J Geriatr Psychiatry; 2014 May; 22(5):427-36. PubMed ID: 23933423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia.
    Sicras-Mainar A; Maurino J; Ruiz-Beato E; Navarro-Artieda R
    Neuropsychiatr Dis Treat; 2015; 11():51-7. PubMed ID: 25565850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs of schizophrenia in Spain.
    Oliva-Moreno J; López-Bastida J; Osuna-Guerrero R; Montejo-González AL; Duque-González B
    Eur J Health Econ; 2006 Sep; 7(3):182-88. PubMed ID: 16850333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilisation of mental health services and costs of patients with schizophrenia in three areas of Spain.
    Haro JM; Salvador-Carulla L; Cabasés J; Madoz V; Vázquez-Barquero JL
    Br J Psychiatry; 1998 Oct; 173():334-40. PubMed ID: 9926039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of schizophrenia in England.
    Mangalore R; Knapp M
    J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study.
    Galante M; Garin O; Sicuri E; Cots F; García-Altés A; Ferrer M; Dominguez À; Alonso J
    PLoS One; 2012; 7(2):e31696. PubMed ID: 22348122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.
    Lefebvre P; Muser E; Joshi K; DerSarkissian M; Bhak RH; Duh MS; Shiner B; Young-Xu Y
    Clin Ther; 2017 Jul; 39(7):1380-1395.e4. PubMed ID: 28641996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care resource use associated with integrated psychological treatment.
    Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
    J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of generalized anxiety disorder in primary care settings: results of the ANCORA study.
    Rovira J; Albarracin G; Salvador L; Rejas J; Sánchez-Iriso E; Cabasés JM
    Community Ment Health J; 2012 Jun; 48(3):372-83. PubMed ID: 22484993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study.
    Haynes VS; Zhu B; Stauffer VL; Kinon BJ; Stensland MD; Xu L; Ascher-Svanum H
    BMC Psychiatry; 2012 Dec; 12():222. PubMed ID: 23216976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice.
    Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Ibáñez-Nolla J
    Lung; 2014 Aug; 192(4):505-18. PubMed ID: 24816902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.